Literature DB >> 7513360

Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.

R A Huff1, J J Corcoran, J K Anderson, M B Abou-Donia.   

Abstract

Although the acute effects of organophosphorus esters are generally ascribed to inhibition of acetylcholinesterase, work in this laboratory and others indicates that organophosphorus insecticides also interact directly with cholinergic receptors. The current study verifies that the insecticide O,O-diethyl O-3,5,6-trichloro-2-pyridinyl phosphorothionate (chlorpyrifos) and its oxon metabolite inhibits acetylcholinesterase (AChE). The metabolite inhibits rat brain AChE three orders of magnitude more rapidly than chlorpyrifos. In addition to their ability to inhibit AChE, these compounds were shown to interact directly with muscarinic receptors of rat striatum. The oxon metabolite bound at low concentrations to muscarinic receptors labeled by the muscarinic agonist [3H] cis-methyldioxolane; chlorpyrifos oxon bound with an IC50 value of 22.1 +/- 3.6 nM. The receptors bound by chlorpyrifos oxon account for approximately 30% of muscarinic receptors of the striatum and are of the m2 subtype. The binding of chlorpyrifos oxon to the m2 receptor results in a covalent modification of the receptor that does not interfere with the ability of the receptor to interact with the agonist carbachol. This receptor modification may be responsible for the inhibition of adenylate cyclase activity by chlorpyrifos oxon. The oxon inhibited adenylate cyclase with an IC50 of 155 +/- 78 nM. The inhibition of adenylate cyclase activity was not blocked by atropine and was additive to that produced by carbachol. The altering of postreceptor signal transduction by chlorpyrifos oxon may interfere with normal cellular signaling, thereby disturbing neurological function. Direct interaction of chlorpyrifos oxon with muscarinic receptors and associated signal transduction is a potential mechanism of neurotoxicity that is independent of AChE inhibition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513360

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  29 in total

1.  Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children.

Authors:  Virginia A Rauh; Robin Garfinkel; Frederica P Perera; Howard F Andrews; Lori Hoepner; Dana B Barr; Ralph Whitehead; Deliang Tang; Robin W Whyatt
Journal:  Pediatrics       Date:  2006-11-20       Impact factor: 7.124

2.  Neurobehavioral assessment of mice following repeated postnatal exposure to chlorpyrifos-oxon.

Authors:  Toby B Cole; Jenna C Fisher; Thomas M Burbacher; Lucio G Costa; Clement E Furlong
Journal:  Neurotoxicol Teratol       Date:  2012-03-07       Impact factor: 3.763

3.  Repeated developmental exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1)-modulated effects on cerebellar gene expression.

Authors:  Toby B Cole; Richard P Beyer; Theo K Bammler; Sarah S Park; Federico M Farin; Lucio G Costa; Clement E Furlong
Journal:  Toxicol Sci       Date:  2011-06-14       Impact factor: 4.849

4.  Effects of chlorpyrifos and chlorpyrifos-oxon on the dynamics and movement of mitochondria in rat cortical neurons.

Authors:  Mary-Louise Middlemore-Risher; Bao-Ling Adam; Nevin A Lambert; Alvin V Terry
Journal:  J Pharmacol Exp Ther       Date:  2011-07-28       Impact factor: 4.030

Review 5.  Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms.

Authors:  A V Terry
Journal:  Pharmacol Ther       Date:  2012-03-20       Impact factor: 12.310

Review 6.  Neurotoxicity in acute and repeated organophosphate exposure.

Authors:  Sean X Naughton; Alvin V Terry
Journal:  Toxicology       Date:  2018-08-23       Impact factor: 4.221

Review 7.  Mass spectrometric analyses of organophosphate insecticide oxon protein adducts.

Authors:  Charles M Thompson; John M Prins; Kathleen M George
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

8.  In vitro sensitivity of cholinesterases and [3H]oxotremorine-M binding in heart and brain of adult and aging rats to organophosphorus anticholinesterases.

Authors:  Nikita Mirajkar; Carey N Pope
Journal:  Biochem Pharmacol       Date:  2008-08-12       Impact factor: 5.858

9.  Comparative effects of oral chlorpyrifos exposure on cholinesterase activity and muscarinic receptor binding in neonatal and adult rat heart.

Authors:  Marcia D Howard; Nikita Mirajkar; Subramanya Karanth; Carey N Pope
Journal:  Toxicology       Date:  2007-06-14       Impact factor: 4.221

10.  Incorporating Low-dose Epidemiology Data in a Chlorpyrifos Risk Assessment.

Authors:  Julie E Goodman; Robyn L Prueitt; Lorenz R Rhomberg
Journal:  Dose Response       Date:  2012-07-30       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.